Detalles de la búsqueda
1.
Peripheral administration of the Class-IIa HDAC inhibitor MC1568 partially protects against nigrostriatal neurodegeneration in the striatal 6-OHDA rat model of Parkinson's disease.
Brain Behav Immun;
102: 151-160, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35217173
2.
LMK235, a small molecule inhibitor of HDAC4/5, protects dopaminergic neurons against neurotoxin- and α-synuclein-induced degeneration in cellular models of Parkinson's disease.
Mol Cell Neurosci;
115: 103642, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34119632
3.
Bioinformatics and Immunohistochemical Analyses Support Preserved Expression of Glial Cell Line-Derived Neurotrophic Factor Receptor RET in Parkinson's.
Mov Disord;
38(6): 1115-1116, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37475614
4.
Growth differentiation factor 5 exerts neuroprotection in an α-synuclein rat model of Parkinson's disease.
Brain;
144(2): e14, 2021 03 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33253375
5.
The neurite growth inhibitory effects of soluble TNFα on developing sympathetic neurons are dependent on developmental age.
Differentiation;
88(4-5): 124-30, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25582843
6.
Human α-synuclein overexpression upregulates SKOR1 in a rat model of simulated nigrostriatal ageing.
Aging Cell;
: e14155, 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38529808
7.
A combined proteomics and bioinformatics analysis of ZNHIT1-interacting proteins reveals a significant enrichment in proteins associated with mitochondrial function.
J Chem Neuroanat;
131: 102288, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37178741
8.
Exposure of foetal neural progenitor cells to IL-1ß impairs their proliferation and alters their differentiation - a role for maternal inflammation?
J Neurochem;
120(6): 964-73, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22192001
9.
Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson's disease.
Neural Regen Res;
17(1): 38-44, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34100424
10.
Gene Co-expression Analysis of the Human Substantia Nigra Identifies ZNHIT1 as an SNCA Co-expressed Gene that Protects Against α-Synuclein-Induced Impairments in Neurite Growth and Mitochondrial Dysfunction in SH-SY5Y Cells.
Mol Neurobiol;
59(5): 2745-2757, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35175558
11.
NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson's Disease.
Mol Neurobiol;
59(1): 61-76, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34623600
12.
Quinacrine and Niclosamide Promote Neurite Growth in Midbrain Dopaminergic Neurons Through the Canonical BMP-Smad Pathway and Protect Against Neurotoxin and α-Synuclein-Induced Neurodegeneration.
Mol Neurobiol;
58(7): 3405-3416, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33713017
13.
The class II histone deacetylases as therapeutic targets for Parkinson's disease.
Neuronal Signal;
4(2): NS20200001, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32714601
14.
The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease.
Neural Regen Res;
15(8): 1432-1436, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31997802
15.
STRAP and NME1 Mediate the Neurite Growth-Promoting Effects of the Neurotrophic Factor GDF5.
iScience;
23(9): 101457, 2020 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32853992
16.
Association of distinct type 1 bone morphogenetic protein receptors with different molecular pathways and survival outcomes in neuroblastoma.
Neuronal Signal;
4(1): NS20200006, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32714600
17.
Gene co-expression analysis of the human substantia nigra identifies BMP2 as a neurotrophic factor that can promote neurite growth in cells overexpressing wild-type or A53T α-synuclein.
Parkinsonism Relat Disord;
64: 194-201, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31000327
18.
Gene Co-expression Analysis Identifies Histone Deacetylase 5 and 9 Expression in Midbrain Dopamine Neurons and as Regulators of Neurite Growth via Bone Morphogenetic Protein Signaling.
Front Cell Dev Biol;
7: 191, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31572723
19.
Nociceptin/Orphanin FQ Inhibits the Survival and Axon Growth of Midbrain Dopaminergic Neurons Through a p38-MAPK Dependent Mechanism.
Mol Neurobiol;
53(10): 7284-7297, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26687234
20.
Mitogen-Activated Protein Kinase Phosphatase (MKP)-1 in Nervous System Development and Disease.
Mol Neurobiol;
51(3): 1158-67, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-24957007